Please login to the form below

Not currently logged in
Email:
Password:

Apogee files two US patent applications for intradermal delivery system

Apogee Technology has filed two US provisional patent applications relating to its intradermal drug delivery technology 

US-headquartered biotech Apogee Technology has filed two US provisional patent applications relating to its intradermal drug delivery technology.  

The new patent applications describe advanced macromolecular formulations and coating methodologies.

Dr Alexander K Andrianov, Apogee's vice-president of R&D, said, "These filings are an important achievement of the company's ongoing research and development programme and are intended to protect rights for formulations with improved coating efficiency, methods and systems for precise dose control."

23rd July 2007

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

Welcome to Frontera Group, where our agencies immerse you in the world of the patient...

Latest intelligence

“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...

Infographics